NorthRock Partners LLC boosted its holdings in Exelon Corporation (NASDAQ:EXC – Free Report) by 4.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,109 shares of the company’s stock after purchasing an additional 354 shares during the quarter. NorthRock Partners LLC’s holdings in Exelon were worth $396,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. GAMMA Investing LLC boosted its stake in Exelon by 26.9% during the first quarter. GAMMA Investing LLC now owns 19,751 shares of the company’s stock worth $910,000 after acquiring an additional 4,183 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Exelon by 141.2% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 269,101 shares of the company’s stock valued at $12,400,000 after purchasing an additional 157,548 shares during the period. Exchange Traded Concepts LLC boosted its position in shares of Exelon by 182.5% during the 1st quarter. Exchange Traded Concepts LLC now owns 28,174 shares of the company’s stock worth $1,298,000 after purchasing an additional 18,201 shares in the last quarter. Brighton Jones LLC bought a new position in shares of Exelon during the 1st quarter worth about $226,000. Finally, Janney Montgomery Scott LLC acquired a new stake in shares of Exelon in the 1st quarter valued at about $6,795,000. 80.92% of the stock is currently owned by institutional investors.
Exelon Price Performance
Shares of NASDAQ:EXC opened at $47.83 on Thursday. The company has a current ratio of 0.95, a quick ratio of 0.85 and a debt-to-equity ratio of 1.66. The stock has a market cap of $48.31 billion, a PE ratio of 18.19, a price-to-earnings-growth ratio of 2.93 and a beta of 0.40. The stock’s fifty day simple moving average is $44.55 and its two-hundred day simple moving average is $44.39. Exelon Corporation has a 1-year low of $35.94 and a 1-year high of $48.11.
Exelon Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Monday, August 11th were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date was Monday, August 11th. Exelon’s payout ratio is presently 60.84%.
Analysts Set New Price Targets
A number of research firms recently weighed in on EXC. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Exelon in a research note on Wednesday, October 8th. Barclays upped their target price on Exelon from $48.00 to $52.00 and gave the stock an “overweight” rating in a research report on Tuesday. Jefferies Financial Group set a $57.00 price target on shares of Exelon in a research report on Wednesday. KeyCorp boosted their price target on shares of Exelon from $37.00 to $42.00 and gave the company an “underweight” rating in a research note on Wednesday. Finally, Morgan Stanley dropped their price objective on shares of Exelon from $50.00 to $49.00 and set an “equal weight” rating on the stock in a research note on Thursday, September 25th. Six research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Exelon presently has a consensus rating of “Hold” and an average target price of $50.10.
Check Out Our Latest Analysis on Exelon
About Exelon
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Read More
- Five stocks we like better than Exelon
- What is Short Interest? How to Use It
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What Do S&P 500 Stocks Tell Investors About the Market?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- What is a buyback in stocks? A comprehensive guide for investors
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Corporation (NASDAQ:EXC – Free Report).
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.